IRAK-4 inhibitors for inflammation.
Interleukin-1 receptor-associated kinases (IRAKs) are key components in the signal transduction pathways utilized by interleukin-1 receptor (IL-1R), interleukin-18 receptor (IL-18R), and Toll-like receptors (TLRs). Out of four members in the mammalian IRAK family, IRAK-4 is considered to be the "master IRAK", the only family member indispensable for IL-1R/TLR signaling. In humans, mutations resulting in IRAK-4 deficiency have been linked to susceptibility to bacterial infections, especially recurrent pyogenic bacterial infections. Furthermore, knock-in experiments by several groups have clearly demonstrated that IRAK-4 requires its kinase activity for its function. Given the critical role of IRAK-4 in inflammatory processes, modulation of IRAK-4 kinase activity presents an attractive therapeutic approach for the treatment of immune and inflammatory diseases. The recent success in the determination of the 3-dimensional structure of the IRAK-4 kinase domain in complex with inhibitors has facilitated the understanding of the mechanistic role of IRAK-4 in immunity and inflammation as well as the development of specific IRAK-4 kinase inhibitors. In this article, we review the biological function of IRAK-4, the structural characteristics of the kinase domain, and the development of small molecule inhibitors targeting the kinase activity. We also review the key pharmacophores required for several classes of inhibitors as well as important features for optimal protein/inhibitor interactions. Lastly, we summarize how these insights can be translated into strategies to develop potent IRAK-4 inhibitors with desired properties as new anti-inflammatory therapeutic agents.
Wang
Zhulun
Z
Amgen Inc, South San Francisco, CA 94080, USA. zwang@amgen.com
Wesche
Holger
H
Stevens
Tracey
T
Walker
Nigel
N
Yeh
Wen-Chen
WC
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D015195:Drug Design; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D053592:Interleukin-1 Receptor-Associated Kinases / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D011487:Protein Conformation; D047428:Protein Kinase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D047428:Protein Kinase Inhibitors; D053592:Interleukin-1 Receptor-Associated Kinases
Mol Immunol. 2009 Apr;46(7):1458-66
19181383
Cell. 1997 Sep 5;90(5):859-69
9298898
Nat Cell Biol. 1999 Nov;1(7):438-43
10559988
Gut. 2002 Jun;50(6):812-20
12010883
Science. 1996 Feb 23;271(5252):1128-31
8599092
Bioorg Med Chem Lett. 2008 Jun 1;18(11):3291-5
18482836
Science. 1997 Nov 28;278(5343):1612-5
9374458
Science. 2003 Mar 28;299(5615):2076-9
12637671
Arthritis Rheum. 2007 Jul;56(7):2192-201
17599732
Bioorg Med Chem Lett. 2003 Sep 15;13(18):3079-82
12941338
J Exp Med. 2007 Oct 1;204(10):2407-22
17893200
Immunol Cell Biol. 2007 Aug-Sep;85(6):490-4
17667933
Structure. 2005 May;13(5):769-78
15893667
Nat Immunol. 2008 Jun;9(6):684-91
18438411
Mol Cell. 2003 Feb;11(2):293-302
12620219
J Exp Med. 2005 Mar 21;201(6):915-23
15767370
Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15416-21
15492225
J Biol Chem. 2007 May 4;282(18):13552-60
17337443
Ann N Y Acad Sci. 2008 Nov;1143:1-20
19076341
J Immunol. 2007 Mar 1;178(5):2641-5
17312103
Immunol Rev. 2007 Dec;220:225-36
17979850
Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):323-40
12220547
Cell Mol Immunol. 2005 Feb;2(1):36-9
16212909
Eur J Immunol. 2008 Mar;38(3):870-6
18286567
Bioorg Med Chem Lett. 2008 Jun 1;18(11):3211-4
18474425
EMBO J. 1997 Sep 15;16(18):5572-81
9312016
Bioorg Med Chem Lett. 2006 Jun 1;16(11):2842-5
16563752
J Biol Chem. 2004 Sep 24;279(39):40653-8
15292196
Blood. 2005 Aug 1;106(3):996-1002
15831699
J Mol Biol. 1999 Mar 12;286(5):1651-62
10064721
Nat Struct Biol. 2001 Dec;8(12):1058-63
11694888
Nat Struct Biol. 1996 Aug;3(8):696-700
8756328
J Mol Biol. 1999 Mar 12;286(5):1633-49
10064720
Immunol Rev. 2008 Dec;226:10-8
19161412
Cell. 2002 Jul 26;110(2):191-202
12150927
Ernst Schering Found Symp Proc. 2007;(3):63-82
18510099
Bioorg Med Chem Lett. 2008 Jun 15;18(12):3656-60
18501603
Structure. 2006 Dec;14(12):1835-44
17161373
J Exp Med. 2007 May 14;204(5):1025-36
17470642
Nature. 1996 Dec 5;384(6608):484-9
8945479
Biochem Biophys Res Commun. 2007 Jan 19;352(3):609-16
17141195
Science. 2004 Mar 19;303(5665):1800-5
15031492
Cell. 2002 May 3;109(3):275-82
12015977
Immunity. 2008 Nov 14;29(5):746-57
19006693
Immunol Rev. 2005 Feb;203:10-20
15661018
Curr Top Microbiol Immunol. 2006;311:1-16
17048703
Immunity. 2005 Nov;23(5):465-78
16286015
J Exp Med. 2007 May 14;204(5):1013-24
17485511
Eur Cytokine Netw. 2006 Dec;17(4):224-52
17353157
Structure. 1999 Jun 15;7(6):651-61
10404594
J Immunol. 1999 Jul 15;163(2):978-84
10395695
Semin Immunol. 2004 Feb;16(1):3-9
14751757
J Biol Chem. 1999 Jul 2;274(27):19403-10
10383454
J Immunol. 2005 Jun 1;174(11):6587-91
15905496
Eur J Immunol. 2007 Dec;37(12):3582-6
18034431
Cell. 1996 Apr 19;85(2):149-58
8612268
Bioorg Med Chem Lett. 2004 Jan 19;14(2):409-12
14698170
Nature. 2002 Apr 18;416(6882):750-6
11923871
Biochemistry. 1993 Mar 9;32(9):2154-61
8443157
Cell. 1993 Feb 26;72(4):515-25
8440018
J Biol Chem. 1997 Aug 22;272(34):21540-7
9261174
J Exp Med. 1998 Jun 15;187(12):2073-9
9625767
Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5567-72
11960013
Cytokine. 2008 Apr;42(1):1-7
18249132